Alec Stranahan
Stock Analyst at B of A Securities
(0.75)
# 2349
Out of 5,340 analysts
31
Total ratings
33.33%
Success rate
10.87%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BEAM Beam Therapeutics | Upgrades: Buy | 42 42 | 17.55 | 139.32% | 1 | Mar 28, 2025 | |
YMAB Y-mAbs Therapeutics | Maintains: Neutral | 14 12 | 4.16 | 188.46% | 5 | Mar 5, 2025 | |
CADL Candel Therapeutics | Initiates Coverage On: Buy | 15 | 5.29 | 183.55% | 1 | Feb 7, 2025 | |
DAWN Day One Biopharmaceu... | Maintains: Buy | 28 25 | 6.47 | 286.4% | 4 | Jan 7, 2025 | |
CRBU Caribou Biosciences | Maintains: Buy | 13 11 | 0.98 | 1022.45% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 5 5 | 1.21 | 313.22% | 2 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 24 6 | 2.81 | 113.52% | 2 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 48 55 | 39.28 | 40.02% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 12 18 | 7.87 | 128.72% | 3 | Jun 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 118 140 | 131.5 | 6.46% | 3 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 42 | 8.16 | 414.71% | 1 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 5 6 | 34.08 | -82.39% | 2 | Dec 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 60 5 | 1.54 | 224.68% | 1 | Dec 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 45 | 46.19 | -2.58% | 1 | Dec 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 58 | n/a | n/a | 1 | May 20, 2022 |